Conessine Treatment Reduces Dexamethasone-Induced Muscle Atrophy by Regulating MuRF1 and Atrogin-1 Expression
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Conessine, a steroidal alkaloid, is a potent histamine H3 antagonist with antimalarial activity. We recently reported that conessine treatment interferes with H2O2-induced cell death by regulating autophagy. However, the cellular signaling pathways involved in conessine treatment are not fully understood. Here, we report that conessine reduces muscle atrophy by interfering with the expression of atrophy-related ubiquitin ligases MuRF-1 and atrogin-1. Promoter reporter assay revealed that conessine treatment inhibits FoxO3a-dependent transcription, NF-κB-dependent transcription, and p53-dependent transcription. We also showed by quantitative RT-PCR and western blot assays that conessine treatment reduced dexamethasone-induced expression of MuRF1 and atrogin-1. Finally, we demonstrated that conessine treatment reduced dexamethasone-induced muscle atrophy using differentiated C2C12 cells. These results collectively suggest that conessine is potentially useful in the treatment of muscle atrophy.
Abstract
Conessine, a steroidal alkaloid, is a potent histamine H3 antagonist with antimalarial activity. We recently reported that conessine treatment interferes with H2O2-induced cell death by regulating autophagy. However, the cellular signaling pathways involved in conessine treatment are not fully understood. Here, we report that conessine reduces muscle atrophy by interfering with the expression of atrophy-related ubiquitin ligases MuRF-1 and atrogin-1. Promoter reporter assay revealed that conessine treatment inhibits FoxO3a-dependent transcription, NF-κB-dependent transcription, and p53-dependent transcription. We also showed by quantitative RT-PCR and western blot assays that conessine treatment reduced dexamethasone-induced expression of MuRF1 and atrogin-1. Finally, we demonstrated that conessine treatment reduced dexamethasone-induced muscle atrophy using differentiated C2C12 cells. These results collectively suggest that conessine is potentially useful in the treatment of muscle atrophy.
참고문헌 (26)
- Bodine SC, "Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx", atrogin-1, 2014, pp.307, E469~E484
- Attaix D, "MAFbx", Atrogin-1 expression is a poor index of muscle proteolysis, 2010, pp.13, 223~224
- Fitts RH, "Functional and structural adaptations of skeletal muscle to microgravity", J. Exp. Biol., 204, pp.3201~3208 (2001)
- Bodine SC, "Identification of ubiquitin ligases required for skeletal muscle atrophy", Science, 294, pp.1704~1708 (2001)[DOI]
- Clarke BA, "The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle", Cell Metab., 6, pp.376~385 (2007)[DOI]
- Sacheck JM, "IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1", Am. J. Physiol. Endocrinol. Metab., 287, pp.E591~E601 (2004)[DOI]
- Senf SM, "Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy", FASEB J., 22, pp.3836~3845 (2008)[DOI]
- Wu CL, "NF-kappaB but not FoxO sites in the MuRF1 promoter are required for transcriptional activation in disuse muscle atrophy", Am. J. Physiol. Cell Physiol., 306, pp.762~767 (2014)[DOI]
- Adams V, "Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice", J. Mol. Biol., 384, pp.48~59 (2008)[DOI]
- Atherton PJ, "Control of skeletal muscle atrophy in response to disuse: clinical", preclinical contentions and fallacies of evidence, 2016, pp.311, E594~E604
- Dua VK, "Anti-malarial property of steroidal alkaloid conessine isolated from the bark of Holarrhena antidysenterica", Malar. J., 12, pp.194~ (2013)[DOI]
- Zirihi GN, "Isolation, characterization and antiplasmodial activity of steroidal alkaloids from Funtumia elastica (Preuss) Stapf", Bioorg. Med. Chem. Lett., 15, pp.2637~2640 (2005)[DOI]
- Paris R, "On a new acquisition in phytotherapy: Holarrhena floribunda and its principal alkaloid: conessine", Gaz. Med. Fr., pp.79~83 (1951)
- Zhao C, "The alkaloid conessine and analogues as potent histamine H3 receptor antagonists", J. Med. Chem., 51, pp.5423~5430 (2008)[DOI]
- Kim H, "Conessine interferes with oxidative stress-induced C2C12 myoblast cell death through inhibition of autophagic flux", PLoS One, 11, pp.e0157096~ (2016)[DOI]
- Zhou C, "Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells", Biochem. Biophys. Res. Commun., 303, pp.130~136 (2003)[DOI]
- Paumelle R, "Hepatocyte growth factor", scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway, 2002, pp.21, 2309~2319
- Park J, "Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis", Proc. Natl. Acad. Sci. USA, 104, pp.17028~17033 (2007)[DOI]
- Kimbrel EA, "The F-box protein beta-TrCp1", Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity, 2009, pp.284, 13033~13044
- Datto MB, "Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism", Proc. Natl. Acad. Sci. USA, 92, pp.5545~5549 (1995)[DOI]
- Namkoong S, "Alpinumisoflavone induces apoptosis and suppresses extracellular signal-regulated kinases", mitogen activated protein kinase and nuclear factor-kappaB pathways in lung tumor cells, 2011, pp.34, 203~208
- Brunet A, "Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a)", Mol. Cell. Biol., 21, pp.952~965 (2001)[DOI]
- Sanchez AM, "AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1", J. Cell. Biochem., 113, pp.695~710 (2012)[DOI]
- Ni HM, "Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity", Am. J. Pathol., 183, pp.1815~1825 (2013)[DOI]
- Murray-Zmijewski F, "A complex barcode underlies the heterogeneous response of p53 to stress", Nat. Rev. Mol. Cell Biol., 9, pp.702~712 (2008)[DOI]
- Datta K, "p53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress", Int. J. Biochem. Cell Biol., 34, pp.148~157 (2002)[DOI]